An overview of disease models for NLRP3 inflammasome over-activation

H Zhang, A Zahid, H Ismail, Y Tang, T Jin… - Expert Opinion on Drug …, 2021 - Taylor & Francis
Introduction: Inflammatory reactions, including those mediated by the NLRP3
inflammasome, maintain the body's homeostasis by removing pathogens, repairing …

[HTML][HTML] Pharmacological inhibitors of the NLRP3 inflammasome

A Zahid, B Li, AJK Kombe, T Jin, J Tao - Frontiers in immunology, 2019 - frontiersin.org
Inflammasomes play a crucial role in innate immunity by serving as signaling platforms
which deal with a plethora of pathogenic products and cellular products associated with …

The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases

H Jiang, T Gong, R Zhou - Advances in immunology, 2020 - Elsevier
The NLRP3 inflammasome is a cytoplasmic multiprotein complex, the assembly of which
can be initiated in response to various exogenous or endogenous danger signals …

[HTML][HTML] Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases

JK Seok, HC Kang, YY Cho, HS Lee, JY Lee - Archives of Pharmacal …, 2021 - Springer
Inflammasomes are cytosolic pattern recognition receptors that recognize pathogen-
associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) …

The research progression of direct NLRP3 inhibitors to treat inflammatory disorders

X Chen, P Zhang, Y Zhang, M Wei, T Tian, D Zhu… - Cellular …, 2024 - Elsevier
The NLRP3 inflammasome represents a cytoplasmic multiprotein complex with the
capability to recognize a wide range of pathogen-derived, environmental, and endogenous …

Strategies for targeting the NLRP3 inflammasome in the clinical and preclinical space

AG Schwaid, KB Spencer - Journal of Medicinal Chemistry, 2020 - ACS Publications
Inhibiting the NLRP3 inflammasome mediates inflammation in an extensive number of
preclinical models. As excitement in this field has grown, several companies have recently …

Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases

CT Vong, HHL Tseng, P Yao, H Yu, S Wang… - Drug Discovery …, 2021 - Elsevier
Highlights•Targeting the NLRP3 inflammasome has shown therapeutic effects in
inflammatory diseases.•The use of specific NLRP3 inhibitors reduces off-target …

Pharmacological inhibition of the NLRP3 inflammasome: structure, molecular activation, and inhibitor-NLRP3 interaction

Q Ma - Pharmacological reviews, 2023 - ASPET
The nucleotide-binding, oligomerization domain-like receptor family pyrin domain containing
3 (NLRP3) inflammasome is a multiprotein complex that combines sensing, regulation, and …

Advances in the molecular mechanisms of NLRP3 inflammasome activators and inactivators

D Liu, X Zeng, X Li, C Cui, R Hou, Z Guo… - Biochemical …, 2020 - Elsevier
NLRP3 inflammasome is an intracellular protein complex that initiates cellular injury via
assembly of NLRP3, ASC and caspase-1 in response to microbial infection and sterile …

NLRP3 inhibitors: Unleashing their therapeutic potential against inflammatory diseases

V Ramalingam - Biochemical Pharmacology, 2023 - Elsevier
The NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome has been
linked to the release of pro-inflammatory cytokines and is essential for innate defence …